POET Technologies Inc of Toronto, Canada – which, through subsidiary OPEL Defense Integrated Systems (ODIS Inc) of Storrs, CT, USA, has developed the proprietary planar-optoelectronic technology (POET) platform for monolithic ...
Tags: POET, III-V-based electronic, Electronics
Evolva and Cargill have signed an agreement to co-develop a sustainable, customisable, and cost-effective fermentation production process for a second family of high-value food and beverage ingredients. This additional collaboration ...
Inazin Power Ltd, a leading developer of large renewable energy projects in the UK, announced the successful development and management of the build and connection of a further 73 MW of large scale solar parks. Working in conjunction with ...
Tags: Metallurgy, Mineral, Energy, Solar
VisLab of the University of Parma has entered into a technical-scientific collaboration agreement with Italian auto components maker Magneti Marelli to study the intelligent vehicles and autonomous driving concept. As part of the deal, ...
Tags: VisLab, Vehicle Technologies
Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 ...
Tags: collaboration agreement, Incyte's oral indoleamine dioxygenase-1, IDO1
Sunesis Pharmaceuticals has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The first agreement, with Biogen Idec, is for global commercial rights to SNS-062, a ...
Tags: Sunesis Pharmaceuticals, Medicine
Victoria Oil & Gas Plc, the emerging African energy utility company, today announces the signing of key customer agreements that places Cameroon operating subsidiary, Gaz du Cameroun (“GDC”), in a strong position to expand gas ...
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody ...
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration ...
Tags: Bispecific Antibodies, Sutro's Cell-Free Protein Synthesis Technology
Boehringer Ingelheim has entered into a research collaboration agreement with and Circuit Therapeutics to discover new ways of treating psychiatric disorders. As per the deal, the companies will combine their research and development ...
Tags: Boehringer, Psychiatric Disorders
Siemens Healthcare Diagnostics and Pfizer have entered into a master collaboration agreement to design, develop and commercialize diagnostic tests for therapeutic products across Pfizer’s pipeline. Pursuant to the terms of the ...
Tags: Siemens, Pfizer, Companion Diagnostics
BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has amended its development and commercialization collaboration agreement with Amgen to extend the period ...
PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, has entered into a five-year strategic collaboration agreement with St. Louis-based Intercon Chemical Company (ICC). The agreement consists of a ...
Tags: PURE Bioscience, Chemical Company
Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
Echo Therapeutics, a medical device company developing its Symphony CGM system as a non-invasive, wireless continuous glucose monitoring system, has entered into a strategic collaboration agreement with Medical Technologies Innovation Asia ...